Amarin Corporation is a drug manufacturers - general business based in the US. Amarin Corporation shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.41 – a decrease of 22.64% over the previous week. Amarin Corporation employs 275 staff and has a trailing 12-month revenue of around $241 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.41 |
|---|---|
| 52-week range | $0.43 - $1.11 |
| 50-day moving average | $0.55 |
| 200-day moving average | $0.62 |
| Wall St. target price | $1.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.10 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.4001 from 2025-03-12
| 1 week (2025-03-06) | -25.12% |
|---|---|
| 1 month (2025-02-14) | -34.67% |
| 3 months (2024-12-13) | -12.12% |
| 6 months (2024-09-13) | -33.32% |
| 1 year (2024-03-13) | -53.64% |
|---|---|
| 2 years (2023-03-13) | -74.19% |
| 3 years (2022-03-11) | 2.96 |
| 5 years (2020-03-13) | 12.55 |
| Revenue TTM | $241 million |
|---|---|
| Gross profit TTM | $136.1 million |
| Return on assets TTM | -3.45% |
| Return on equity TTM | -7.26% |
| Profit margin | -16.33% |
| Book value | $1.29 |
| Market Capitalization | $218 million |
TTM: trailing 12 months
We're not expecting Amarin Corporation to pay a dividend over the next 12 months.
Amarin Corporation's shares were split on a 1:10 basis on 17 January 2008 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin Corporation shares which in turn could have impacted Amarin Corporation's share price.
Over the last 12 months, Amarin Corporation's shares have ranged in value from as little as $0.4303 up to $1.11. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin Corporation's is 1.831. This would suggest that Amarin Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co. , Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999.
Spot dogecoin ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
We analyzed a number of bitcoin ETFs to determine which are best to invest in.
Arrived offers a simple way to invest in real estate rental properties.
3 Northwestern Mutual wealth management alternatives to consider.
Investing in mutual funds offers instant diversification. Learn more.
What you need to know about investing in the leading indicator for the overall US stock market.
Here’s what you need to know about how to buy and sell stocks online in this easy to follow, step-by-step guide.